We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protein Found to Limit Damage of Acute Brain Injury

By Biotechdaily staff writers
Posted on 31 Jul 2003
Scientists have identified a protein with the ability to limit nuerologic damage induced by stroke or trauma and thereby has the potential to improve the long-term outcome of acute brain injury. More...
Their findings were reported in the July 13, 2003, online issue of Nature Medicine.

In the process of identifying new mechanisms of brain protection by using a genomics approach, the researchers found the gene encoding uncoupling protein-2 (UCP-2) to be up-regulated in response to short episodes of reduced blood flow. Further analysis revealed that UPC-2 displayed a marked neuroprotective effect in experimental mouse models of stroke and brain trauma and in vitro models of neuronal death, indicating that UCP-2 is potentially protective against human stroke and brain trauma. The research was conducted by AGY Therapeutics, Inc. (So. San Francisco, CA, USA; www.agyinc.com), in collaboration with scientists at the Wallenberg Neuroscience Center (Sweden), the State University of Campinas (Brazil), and the University of California, Davis (USA).

"Following stroke or serious head injury, a cascade of events is initiated in the vicinity of the damage that results in the programmed cell death of neurons, which is responsible for many of the long-term debilitating effects of brain trauma,” said Karoly Nikolich, Ph.D., founder and chief scientific officer, AGY Therapeutics.”




Related Links:
AGY

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: POC fingerstick blood testing enables faster hepatitis B DNA testing outside centralized laboratories (Photo courtesy of Conor Ashleigh)

POC Testing for Hepatitis B DNA as Effective as Traditional Laboratory Testing

Hepatitis B is a viral infection that attacks the liver and can lead to cirrhosis, liver failure, and liver cancer over time. Despite being preventable through vaccination and treatable in its chronic... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.